Fact illékonyság
Mi az Fact illékonyság?
A illékonyság az Fact, Inc. - 7.00%
Mi a illékonyság meghatározása?
A volatilitás vagy az átlagos valódi tartomány százalék (ATRP 14) a záróár százalékában kifejezve.
Average true range percent (ATRP) measures volatility on a relative level. This is opposed to the ATR, which measures volatility on an absolute level. ATRP allows securities to be compared whereas ATR does not. That means lower-priced stocks won't necessarily have lower ATR values than higher-priced stocks.
The period used in the calculation is 14 days and the normalized indicator oscillates between 0 and 100 percent of recent price variation. Importantly, the indicator doesn't predict the direction of price but it describes the current volatility. The volatility is comparable across all securities and all markets.
Volatility expresses the degree of price movement. The use of ATRP as volatility compared to ATR is preferred in cases when different securities or different time periods are compared. Examples are stock screening, filtering strategies, and studying seasonality and volatility patterns over long periods of time and different markets
illékonyság a Industrials szektor a OTC-on cégekben a Fact -hoz képest
Mit csinál Fact?
Fact, Inc. engages in the art verification and authentication, sports memorabilia, and fine art businesses. It is developing a front-end user interface, as well as modifying existing ballistics firmware for a comprehensive verification, tracking, and reporting system using white light interferometry to take a non-destructive 3D digital fingerprint of the art using approximately 100,000 unique images. The company was formerly known as Tiburon International Trading Corp. and changed its name to Fact, Inc. in November 2020. FACT, Inc. is headquartered in Toronto, Canada. As of October 5, 2020, Fact, Inc. operates as a subsidiary of Kryptos Art Technologies, Inc.
illékonyság -hoz hasonló cégek Fact
- Nordic Waterproofing A/S nak illékonyság 6.99% van
- Indian Terrain Fashions nak illékonyság 6.99% van
- K9 Gold nak illékonyság 6.99% van
- AksharChem (India) nak illékonyság 6.99% van
- Dhanvarsha Finvest nak illékonyság 6.99% van
- Therapix Biosciences nak illékonyság 6.99% van
- Fact nak illékonyság 7.00% van
- Esperion Therapeutics nak illékonyság 7.01% van
- Ophir Gold Corp nak illékonyság 7.01% van
- Oceanus Resources nak illékonyság 7.01% van
- FIGS nak illékonyság 7.01% van
- dynaCERT nak illékonyság 7.01% van
- Beam Therapeutics nak illékonyság 7.01% van